Allogene Therapeutics (ALLO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Sol Strategies has shown operational progress and institutional traction, but remains entirely dependent on volatile Solana ...

Welcome to the ONGC Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...

Recent trading activity from some of Wall Street's most-followed investors shows a clear pattern between some of the hottest ...

Large language and deep learning computing models – two systems generally thought of as simply AI – are commonly used these ...

Cramer offered a broader perspective and explained that on most days, individual stocks respond either to the movements of ...

On Tuesday, he noted that the bond market heavily influenced stock prices. He highlighted that every downward movement in bond prices, which translates to higher interest rates, was met with negative ...

Learn how to read a stock chart to make smarter, more calculated, and confident trading and investing decisions.

Ivanhoe Electric (IE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

TransMedics (TMDX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...